Proteomic analysis of colorectal cancer metastasis: Stathmin-1 revealed as a player in cancer cell migration and prognostic marker

Journal of Proteome Research

Volumn 11, Issue 2, 2012, Pages 1433-1445

  Tan, Hwee Tong ^a   Wu, Wei ^a   Ng, Yi Zhen ^a   Zhang, Xuxiao ^a   Yan, Benedict ^b   Ong, Chee Wee ^b   Tan, Sandra ^c   Salto Tellez, Manuel ^b   Hooi, Shing Chuan ^a   Chung, Maxey C M ^a,c  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

colorectal cancer; metastasis; prognosis; proteomics; Stathmin 1

Indexed keywords

PEPTIDES AND PROTEINS; STATHMIN 1; UNCLASSIFIED DRUG;

ADULT; ANGIOGENESIS; ARTICLE; CANCER CELL CULTURE; CANCER PROGNOSIS; CELL ADHESION; CELL INVASION; CELL MIGRATION; COLONY FORMATION; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEOMICS; SIGNAL TRANSDUCTION; UPREGULATION;

AGED; CELL ADHESION; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL MOVEMENT; COLORECTAL NEOPLASMS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM PROTEINS; PROGNOSIS; PROTEOME; PROTEOMICS; STATHMIN; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84863069824     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr2010956     Document Type: Article

References (68)

1. Ballantyne, G. H.; Quin, J. Surgical treatment of liver metastases in patients with colorectal cancer Cancer 1993, 71 (12 Suppl) 4252-66
2. Gupta, G. P.; Massague, J. Cancer metastasis: building a framework Cell 2006, 127 (4) 679-95
3. Zhang, Y.-T.; Geng, Y.-P.; Si, L.-S.; Wang, Y.-L. Proteomic analysis of differentially expressed proteins between metastatic and non-metastatic human colorectal carcinoma cell lines Eur. J. Gastroenterol. Hepatol. 2005, 17 (7) 725-32
4. Katayama, M.; Nakano, H.; Ishiuchi, A.; Wu, W.; Oshima, R.; Sakurai, J.; Nishikawa, H.; Yamaguchi, S.; Otsubo, T. Protein pattern difference in the colon cancer cell lines examined by two-dimensional differential in-gel electrophoresis and mass spectrometry Surg. Today 2006, 36 (12) 1085-93
5. Brunagel, G.; Schoen, R. E.; Bauer, A. J.; Vietmeier, B. N.; Getzenberg, R. H. Nuclear matrix protein alterations associated with colon cancer metastasis to the liver Clin. Cancer Res. 2002, 8 (10) 3039-45
6. Pei, H.; Zhu, H.; Zeng, S.; Li, Y.; Yang, H.; Shen, L.; Chen, J.; Zeng, L.; Fan, J.; Li, X.; Gong, Y.; Shen, H. Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer J. Proteome Res. 2007, 6 (7) 2495-501
7. Xue, H.; Lu, B.; Zhang, J.; Wu, M.; Huang, Q.; Wu, Q.; Sheng, H.; Wu, D.; Hu, J.; Lai, M. Identification of serum biomarkers for colorectal cancer metastasis using a differential secretome approach J. Proteome Res. 2010, 9 (1) 545-55
8. Zhao, L.; Liu, L.; Wang, S.; Zhang, Y. F.; Yu, L.; Ding, Y. Q. Differential proteomic analysis of human colorectal carcinoma cell lines metastasis-associated proteins J. Cancer Res. Clin. Oncol. 2007, 133 (10) 771-82
9. Tay, P. N.; Tan, P.; Lan, Y.; Leung, C. H.; Laban, M.; Tan, T. C.; Ni, H.; Manikandan, J.; Rashid, S. B.; Yan, B.; Yap, C. T.; Lim, L. H.; Lim, Y. C.; Hooi, S. C. Palladin, an actin-associated protein, is required for adherens junction formation and intercellular adhesion in HCT116 colorectal cancer cells Int. J. Oncol. 2010, 37 (4) 909-26
10. Tan, H. T.; Zubaidah, R. M.; Tan, S.; Hooi, S. C.; Chung, M. C. 2-D DIGE analysis of butyrate-treated HCT-116 cells after enrichment with heparin affinity chromatography J. Proteome Res. 2006, 5 (5) 1098-106
11. Zubaidah, R. M.; Tan, G. S.; Tan, S. B.; Lim, S. G.; Lin, Q.; Chung, M. C. 2-D DIGE profiling of hepatocellular carcinoma tissues identified isoforms of far upstream binding protein (FUBP) as novel candidates in liver carcinogenesis Proteomics 2008, 8 (23-24) 5086-96
12. Kersey, P. J.; Duarte, J.; Williams, A.; Karavidopoulou, Y.; Birney, E.; Apweiler, R. The International Protein Index: an integrated database for proteomics experiments Proteomics 2004, 4 (7) 1985-8
13. Fidler, I. J. Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture Cancer Res. 1990, 50 (19) 6130-8
14. Hanash, S. M.; Strahler, J. R.; Kuick, R.; Chu, E. H.; Nichols, D. Identification of a polypeptide associated with the malignant phenotype in acute leukemia J. Biol. Chem. 1988, 263 (26) 12813-5
15. Ghosh, R.; Gu, G.; Tillman, E.; Yuan, J.; Wang, Y.; Fazli, L.; Rennie, P. S.; Kasper, S. Increased expression and differential phosphorylation of stathmin may promote prostate cancer progression Prostate 2007, 67 (10) 1038-52
16. Alaiya, A. A.; Franzen, B.; Fujioka, K.; Moberger, B.; Schedvins, K.; Silfversvard, C.; Linder, S.; Auer, G. Phenotypic analysis of ovarian carcinoma: polypeptide expression in benign, borderline and malignant tumors Int. J. Cancer 1997, 73 (5) 678-83
17. Curmi, P. A.; Nogues, C.; Lachkar, S.; Carelle, N.; Gonthier, M. P.; Sobel, A.; Lidereau, R.; Bieche, I. Overexpression of stathmin in breast carcinomas points out to highly proliferative tumours Br. J. Cancer 2000, 82 (1) 142-50
18. Alli, E.; Bash-Babula, J.; Yang, J. M.; Hait, W. N. Effect of stathmin on the sensitivity to antimicrotubule drugs in human breast cancer Cancer Res. 2002, 62 (23) 6864-9
19. Brattsand, G. Correlation of oncoprotein 18/stathmin expression in human breast cancer with established prognostic factors Br. J. Cancer 2000, 83 (3) 311-8
20. Abal, M.; Obrador-Hevia, A.; Janssen, K. P.; Casadome, L.; Menendez, M.; Carpentier, S.; Barillot, E.; Wagner, M.; Ansorge, W.; Moeslein, G.; Fsihi, H.; Bezrookove, V.; Reventos, J.; Louvard, D.; Capella, G.; Robine, S. APC inactivation associates with abnormal mitosis completion and concomitant BUB1B/MAD2L1 up-regulation Gastroenterology 2007, 132 (7) 2448-58
21. Zheng, P.; Liu, Y. X.; Chen, L.; Liu, X. H.; Xiao, Z. Q.; Zhao, L.; Li, G. Q.; Zhou, J.; Ding, Y. Q.; Li, J. M. Stathmin, a new target of PRL-3 identified by proteomic methods, plays a key role in progression and metastasis of colorectal cancer J. Proteome Res. 2010, 9 (10) 4897-905
22. Chen, Y.; Lin, M. C.; Yao, H.; Wang, H.; Zhang, A. Q.; Yu, J.; Hui, C. K.; Lau, G. K.; He, M. L.; Sung, J.; Kung, H. F. Lentivirus-mediated RNA interference targeting enhancer of zeste homolog 2 inhibits hepatocellular carcinoma growth through down-regulation of stathmin Hepatology 2007, 46 (1) 200-8
23. Yuan, R. H.; Jeng, Y. M.; Chen, H. L.; Lai, P. L.; Pan, H. W.; Hsieh, F. J.; Lin, C. Y.; Lee, P. H.; Hsu, H. C. Stathmin overexpression cooperates with p53 mutation and osteopontin overexpression, and is associated with tumour progression, early recurrence, and poor prognosis in hepatocellular carcinoma J. Pathol. 2006, 209 (4) 549-58
24. Singer, S.; Ehemann, V.; Brauckhoff, A.; Keith, M.; Vreden, S.; Schirmacher, P.; Breuhahn, K. Protumorigenic overexpression of stathmin/Op18 by gain-of-function mutation in p53 in human hepatocarcinogenesis Hepatology 2007, 46 (3) 759-68
25. Teraoka, H.; Sawada, T.; Nishihara, T.; Yashiro, M.; Ohira, M.; Ishikawa, T.; Nishino, H.; Hirakawa, K. Enhanced VEGF production and decreased immunogenicity induced by TGF-beta 1 promote liver metastasis of pancreatic cancer Br. J. Cancer 2001, 85 (4) 612-7
26. Li, C.; Tan, Y. X.; Zhou, H.; Ding, S. J.; Li, S. J.; Ma, D. J.; Man, X. B.; Hong, Y.; Zhang, L.; Li, L.; Xia, Q. C.; Wu, J. R.; Wang, H. Y.; Zeng, R. Proteomic analysis of hepatitis B virus-associated hepatocellular carcinoma: Identification of potential tumor markers Proteomics 2005, 5 (4) 1125-39
27. Gan, L.; Guo, K.; Li, Y.; Kang, X.; Sun, L.; Shu, H.; Liu, Y. Up-regulated expression of stathmin may be associated with hepatocarcinogenesis Oncol. Rep. 2010, 23 (4) 1037-43
28. Curmi, P. A.; Andersen, S. S.; Lachkar, S.; Gavet, O.; Karsenti, E.; Knossow, M.; Sobel, A. The stathmin/tubulin interaction in vitro J. Biol. Chem. 1997, 272 (40) 25029-36
29. Manna, T.; Thrower, D.; Miller, H. P.; Curmi, P.; Wilson, L. Stathmin strongly increases the minus end catastrophe frequency and induces rapid treadmilling of bovine brain microtubules at steady state in vitro J. Biol. Chem. 2006, 281 (4) 2071-8
30. Koppel, J.; Boutterin, M. C.; Doye, V.; Peyro-Saint-Paul, H.; Sobel, A. Developmental tissue expression and phylogenetic conservation of stathmin, a phosphoprotein associated with cell regulations J. Biol. Chem. 1990, 265 (7) 3703-7
31. Bieche, I.; Maucuer, A.; Laurendeau, I.; Lachkar, S.; Spano, A. J.; Frankfurter, A.; Levy, P.; Manceau, V.; Sobel, A.; Vidaud, M.; Curmi, P. A. Expression of stathmin family genes in human tissues: non-neural-restricted expression for SCLIP Genomics 2003, 81 (4) 400-10
32. Steinmetz, M. O. Structure and thermodynamics of the tubulin-stathmin interaction J. Struct. Biol. 2007, 158 (2) 137-47
33. Jourdain, L.; Curmi, P.; Sobel, A.; Pantaloni, D.; Carlier, M. F. Stathmin: a tubulin-sequestering protein which forms a ternary T2S complex with two tubulin molecules Biochemistry 1997, 36 (36) 10817-21
34. Gavet, O.; Ozon, S.; Manceau, V.; Lawler, S.; Curmi, P.; Sobel, A. The stathmin phosphoprotein family: intracellular localization and effects on the microtubule network J. Cell Sci. 1998, 111 (Pt 22) 3333-46
35. Nogales, E.; Wang, H. W. Structural intermediates in microtubule assembly and disassembly: how and why? Curr. Opin. Cell Biol. 2006, 18 (2) 179-84
36. Cassimeris, L. Accessory protein regulation of microtubule dynamics throughout the cell cycle Curr. Opin. Cell Biol. 1999, 11 (1) 134-41
37. Rubin, C. I.; Atweh, G. F. The role of stathmin in the regulation of the cell cycle J. Cell Biochem. 2004, 93 (2) 242-50
38. Iancu-Rubin, C.; Atweh, G. F. p27(Kip1) and stathmin share the stage for the first time Trends Cell Biol. 2005, 15 (7) 346-8
39. Johnsen, J. I.; Aurelio, O. N.; Kwaja, Z.; Jorgensen, G. E.; Pellegata, N. S.; Plattner, R.; Stanbridge, E. J.; Cajot, J. F. p53-mediated negative regulation of stathmin/Op18 expression is associated with G(2)/M cell-cycle arrest Int. J. Cancer 2000, 88 (5) 685-91
40. Giampietro, C.; Luzzati, F.; Gambarotta, G.; Giacobini, P.; Boda, E.; Fasolo, A.; Perroteau, I. Stathmin expression modulates migratory properties of GN-11 neurons in vitro Endocrinology 2005, 146 (4) 1825-34
41. Ng, D. C.; Lin, B. H.; Lim, C. P.; Huang, G.; Zhang, T.; Poli, V.; Cao, X. Stat3 regulates microtubules by antagonizing the depolymerization activity of stathmin J. Cell Biol. 2006, 172 (2) 245-57
42. Jin, K.; Mao, X. O.; Cottrell, B.; Schilling, B.; Xie, L.; Row, R. H.; Sun, Y.; Peel, A.; Childs, J.; Gendeh, G.; Gibson, B. W.; Greenberg, D. A. Proteomic and immunochemical characterization of a role for stathmin in adult neurogenesis FASEB J. 2004, 18 (2) 287-99
43. Rodriguez, O. C.; Schaefer, A. W.; Mandato, C. A.; Forscher, P.; Bement, W. M.; Waterman-Storer, C. M. Conserved microtubule-actin interactions in cell movement and morphogenesis Nat. Cell Biol. 2003, 5 (7) 599-609
44. Baldassarre, G.; Belletti, B.; Nicoloso, M. S.; Schiappacassi, M.; Vecchione, A.; Spessotto, P.; Morrione, A.; Canzonieri, V.; Colombatti, A. p27(Kip1)-stathmin interaction influences sarcoma cell migration and invasion Cancer Cell 2005, 7 (1) 51-63
45. Belletti, B.; Nicoloso, M. S.; Schiappacassi, M.; Berton, S.; Lovat, F.; Wolf, K.; Canzonieri, V.; D'Andrea, S. Zucchetto, A.; Friedl, P.; Colombatti, A.; Baldassarre, G., Stathmin activity influences sarcoma cell shape, motility, and metastatic potential Mol. Biol. Cell 2008, 19 (5) 2003-13
46. Langenickel, T. H.; Olive, M.; Boehm, M.; San, H.; Crook, M. F.; Nabel, E. G. KIS protects against adverse vascular remodeling by opposing stathmin-mediated VSMC migration in mice J. Clin. Invest. 2008, 118 (12) 3848-59
47. Verma, N. K.; Dourlat, J.; Davies, A. M.; Long, A.; Liu, W. Q.; Garbay, C.; Kelleher, D.; Volkov, Y. STAT3-stathmin interactions control microtubule dynamics in migrating T-cells J. Biol. Chem. 2009, 284 (18) 12349-62
48. Singer, S.; Malz, M.; Herpel, E.; Warth, A.; Bissinger, M.; Keith, M.; Muley, T.; Meister, M.; Hoffmann, H.; Penzel, R.; Gdynia, G.; Ehemann, V.; Schnabel, P. A.; Kuner, R.; Huber, P.; Schirmacher, P.; Breuhahn, K. Coordinated expression of stathmin family members by far upstream sequence element-binding protein-1 increases motility in non-small cell lung cancer Cancer Res. 2009, 69 (6) 2234-43
49. Liang, X. J.; Choi, Y.; Sackett, D. L.; Park, J. K. Nitrosoureas inhibit the stathmin-mediated migration and invasion of malignant glioma cells Cancer Res. 2008, 68 (13) 5267-72
50. Wei, S. H.; Lin, F.; Wang, X.; Gao, P.; Zhang, H. Z. Prognostic significance of stathmin expression in correlation with metastasis and clinicopathological characteristics in human ovarian carcinoma Acta Histochem. 2008, 110 (1) 59-65
51. Li, N.; Jiang, P.; Du, W.; Wu, Z.; Li, C.; Qiao, M.; Yang, X.; Wu, M. Siva1 suppresses epithelial-mesenchymal transition and metastasis of tumor cells by inhibiting stathmin and stabilizing microtubules Proc. Natl. Acad. Sci. U.S.A. 2011, 108 (31) 12851-6
52. Yeap, Y. Y.; Ng, I. H.; Badrian, B.; Nguyen, T. V.; Yip, Y. Y.; Dhillon, A. S.; Mutsaers, S. E.; Silke, J.; Bogoyevitch, M. A.; Ng, D. C. c-Jun N-terminal kinase/c-Jun inhibits fibroblast proliferation by negatively regulating the levels of stathmin/oncoprotein 18 Biochem. J. 2010, 430 (2) 345-54
53. Zhang, H. Z.; Wang, Y.; Gao, P.; Lin, F.; Liu, L.; Yu, B.; Ren, J. H.; Zhao, H.; Wang, R. Silencing stathmin gene expression by survivin promoter-driven siRNA vector to reverse malignant phenotype of tumor cells Cancer Biol. Ther. 2006, 5 (11) 1457-61
54. Melhem, R. F.; Zhu, X. X.; Hailat, N.; Strahler, J. R.; Hanash, S. M. Characterization of the gene for a proliferation-related phosphoprotein (oncoprotein 18) expressed in high amounts in acute leukemia J. Biol. Chem. 1991, 266 (27) 17747-53
55. Hanash, S. M.; Teichroew, D. Mining the human proteome: experience with the human lymphoid protein database Electrophoresis 1998, 19 (11) 2004-9
56. Lei, Y.; Huang, K.; Gao, C.; Lau, Q. C.; Pan, H.; Xie, K.; Li, J.; Liu, R.; Zhang, T.; Xie, N.; Nai, H. S.; Wu, H.; Dong, Q.; Zhao, X.; Nice, E. C.; Huang, C.; Wei, Y. Proteomics identification of ITGB3 as a key regulator in reactive oxygen species-induced migration and invasion of colorectal cancer cells Mol. Cell. Proteomics 2011, 10 (10) M110 005397
57. Kruh, J. Effects of sodium butyrate, a new pharmacological agent, on cells in culture Mol. Cell. Biochem. 1982, 42 (2) 65-82
58. McIntyre, A.; Gibson, P. R.; Young, G. P. Butyrate production from dietary fibre and protection against large bowel cancer in a rat model Gut 1993, 34 (3) 386-91
59. Zeng, H.; Briske-Anderson, M. Prolonged butyrate treatment inhibits the migration and invasion potential of HT1080 tumor cells J. Nutr. 2005, 135 (2) 291-5
60. Li, X.; Mikkelsen, I. M.; Mortensen, B.; Winberg, J. O.; Huseby, N. E. Butyrate reduces liver metastasis of rat colon carcinoma cells in vivo and resistance to oxidative stress in vitro Clin. Exp. Metastasis 2004, 21 (4) 331-8
61. Douillard, J. Y.; Bennouna, J.; Vavasseur, F.; Deporte-Fety, R.; Thomare, P.; Giacalone, F.; Meflah, K. Phase I trial of interleukin-2 and high-dose arginine butyrate in metastatic colorectal cancer Cancer Immunol. Immunother. 2000, 49 (1) 56-61
62. Barshishat, M.; Levi, I.; Benharroch, D.; Schwartz, B. Butyrate down-regulates CD44 transcription and liver colonisation in a highly metastatic human colon carcinoma cell line Br. J. Cancer 2002, 87 (11) 1314-20
63. Mistry, S. J.; Atweh, G. F. Role of stathmin in the regulation of the mitotic spindle: potential applications in cancer therapy Mt Sinai J. Med. 2002, 69 (5) 299-304
64. Walter-Yohrling, J.; Cao, X.; Callahan, M.; Weber, W.; Morgenbesser, S.; Madden, S. L.; Wang, C.; Teicher, B. A. Identification of genes expressed in malignant cells that promote invasion Cancer Res. 2003, 63 (24) 8939-47
65. Bhat, K. M.; Setaluri, V. Microtubule-associated proteins as targets in cancer chemotherapy Clin. Cancer Res. 2007, 13 (10) 2849-54
66. Trovik, J.; Wik, E.; Stefansson, I. M.; Marcickiewicz, J.; Tingulstad, S.; Staff, A. C.; Njolstad, T. S.; Vandenput, I.; Amant, F.; Akslen, L. A.; Salvesen, H., Stathmin overexpression identifies high risk patients and lymph node metastasis in endometrial cancer. Clin. Cancer Res. 2011.
67. Hsieh, S. Y.; Huang, S. F.; Yu, M. C.; Yeh, T. S.; Chen, T. C.; Lin, Y. J.; Chang, C. J.; Sung, C. M.; Lee, Y. L.; Hsu, C. Y. Stathmin1 overexpression associated with polyploidy, tumor-cell invasion, early recurrence, and poor prognosis in human hepatoma Mol. Carcinog. 2010, 49 (5) 476-87
68. Ogino, S.; Nosho, K.; Baba, Y.; Kure, S.; Shima, K.; Irahara, N.; Toyoda, S.; Chen, L.; Kirkner, G. J.; Wolpin, B. M.; Chan, A. T.; Giovannucci, E. L.; Fuchs, C. S. A cohort study of STMN1 expression in colorectal cancer: body mass index and prognosis Am. J. Gastroenterol. 2009, 104 (8) 2047-56